Michael R Charlton Selected Research

Autoimmune Hepatitis

4/2005	Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
7/2003	Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael R Charlton Research Topics

Disease

18	Fibrosis (Cirrhosis) 01/2024 - 04/2002
16	Infections 11/2023 - 04/2002
14	Non-alcoholic Fatty Liver Disease 01/2024 - 08/2011
11	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 03/2007
9	Hepatitis C 02/2016 - 01/2002
8	Chronic Hepatitis C 02/2016 - 04/2002
6	Liver Diseases (Liver Disease) 11/2023 - 04/2002
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 09/2011
4	Obesity 01/2018 - 06/2006
3	Neoplasms (Cancer) 01/2020 - 04/2002
3	Inflammation (Inflammations) 01/2018 - 06/2006
2	Chronic Hepatitis B 09/2020 - 06/2003
2	Fatty Liver 01/2020 - 05/2014
2	Alcoholic Fatty Liver 01/2019 - 01/2018
2	Heart Diseases (Heart Disease) 01/2017 - 01/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2011
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2016 - 11/2012
2	Disease Progression 09/2014 - 07/2003
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2014 - 07/2010
2	Hepatitis 05/2014 - 10/2002
2	Insulin Resistance 09/2011 - 06/2006
2	Hypertension (High Blood Pressure) 01/2011 - 08/2010
2	End Stage Liver Disease 08/2010 - 04/2005
2	Autoimmune Hepatitis 04/2005 - 07/2003
1	Nausea 01/2024
1	Diarrhea 01/2024
1	Hepatic Encephalopathy 11/2023
1	Liver Failure 11/2023
1	Dysbiosis 01/2023
1	Bone Diseases (Bone Disease) 09/2020
1	Coinfection 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Necrosis 01/2018
1	Virus Diseases (Viral Diseases) 02/2016
1	Alcoholic Hepatitis 01/2016
1	Hepatitis E 09/2015
1	Chronic Renal Insufficiency 09/2014
1	Anemia 05/2014
1	Overweight 08/2013

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2015
6	Antiviral Agents (Antivirals)IBA 01/2020 - 04/2002
4	Ribavirin (Virazole)FDA LinkGeneric 09/2015 - 06/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2002
3	InterferonsIBA 05/2014 - 06/2006
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 06/2003
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2011
2	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2013
2	nasIBA 01/2019 - 07/2003
2	selonsertibIBA 01/2019 - 01/2018
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2015 - 03/2007
2	telaprevirIBA 05/2014 - 07/2013
2	RNA (Ribonucleic Acid)IBA 01/2013 - 09/2010
2	CreatinineIBA 09/2012 - 08/2010
2	SteroidsIBA 12/2011 - 09/2002
1	resmetiromIBA 01/2024
1	Thyroid Hormone Receptors beta (TR beta)IBA 01/2024
1	Bile Acids and Salts (Bile Acids)IBA 11/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2023
1	Lactulose (Duphalac)FDA LinkGeneric 11/2023
1	DisaccharidesIBA 11/2023
1	Volatile Fatty AcidsIBA 11/2023
1	CholesterolIBA 01/2023
1	FructoseIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Drinking WaterIBA 01/2023
1	tenofovir alafenamideIBA 09/2020
1	entecavir FDA Link 09/2020
1	Tenofovir (Viread)FDA Link 09/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Hepatitis B e AntigensIBA 01/2020
1	pembrolizumabIBA 01/2020
1	NivolumabIBA 01/2020
1	IpilimumabIBA 01/2020
1	SulfatasesIBA 01/2020
1	Protons (Proton)IBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 03/2018
1	simtuzumabIBA 01/2018
1	CollagenIBA 01/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2018
1	MAP Kinase Kinase Kinase 5IBA 01/2018
1	Protein Kinases (Protein Kinase)IBA 04/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2016
1	fasudil (AT 877)IBA 04/2016
1	LipidsIBA 04/2016
1	PalmitatesIBA 04/2016
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 04/2016
1	Neutralizing AntibodiesIBA 09/2014
1	AntibodiesIBA 09/2014
1	Broadly Neutralizing AntibodiesIBA 09/2014
1	Serum AlbuminIBA 08/2014
1	Erythropoietin FDA Link 05/2014
1	Growth Hormone (Somatotropin)IBA 05/2014

Therapy/Procedure

36	Liver Transplantation 01/2019 - 04/2002
8	Therapeutics 01/2024 - 04/2002
7	Transplantation 01/2016 - 04/2002
2	Bariatric Surgery 01/2018 - 11/2011
2	Drug Tapering 05/2014 - 07/2013
1	Immunotherapy 01/2020
1	Drug Therapy (Chemotherapy) 05/2016